S
SDS
vs
W
WIG20
Over the past 12 months, SDS has underperformed WIG20, delivering a return of +2% compared to the WIG20's +29% growth.
Stocks Performance
SDS vs WIG20
Performance By Year
SDS vs WIG20
Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.
Sds Optic SA
Glance View
SDS Optic SA engages in the development of biochemistry, engineering, and fiber optic technologies solutions, which can be used in cancer diagnosis and treatment. The company is headquartered in Lublin, Woj. Lubelskie. The company went IPO on 2022-03-15. The Company’s primary research activity relates to the oncology sector. The Firm wishes to develop a method for early breast cancer diagnosis. The current method of diagnosis relies on biopsy and histopathology. The purpose of the tests is to identify cancer markers. The firm tries to implement InProbe method, which is faster and more accurate- the method should be able to provide results within 20 minutes. The firm is also engaged in research regarding different kinds of diseases such as fungal diseases. The firm cooperates with specialists from different fields such as biology, medicine, technology, and sciences related to medicine.
